Edoxaban in venous thromboembolism and stroke prevention: an appraisal

Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic risk in both atrial fibrillation (AF) and venous thromboembolism (VTE). After decades of the sole therapeutic oral anticoagulation option being warfarin, the introduction of non-vitamin K antagonist oral anticoagulants...

Descripción completa

Detalles Bibliográficos
Autores principales: Proietti, Marco, Lip, Gregory YH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778780/
https://www.ncbi.nlm.nih.gov/pubmed/27013883
http://dx.doi.org/10.2147/VHRM.S81569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778780/
https://www.ncbi.nlm.nih.gov/pubmed/27013883
http://dx.doi.org/10.2147/VHRM.S81569

Ejemplares similares